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Acapsular clinical Staphylococcus aureus isolates lack agr function
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Abstract
Staphylococcus aureus is a major human pathogen causing community- and hospital-acquired infections. Capsule production of S. aureus
confers protection against host defence. There is a lack of information concerning the association of capsular polysaccharide (CP)
expression and activity of the accessory gene regulator (agr) in clinical S. aureus isolates. Production of CP and agr expression were assessed
in 195 S. aureus isolates from infected patients at a German University Hospital. Northern blot analysis revealed that S. aureus strains with a
non-functional agr locus were more likely to be CP-negative than strains with a functional agr locus.
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Abstract
We investigated the effect of Mycobacterium tuberculosis culture supernatant added to sputum cultures collected during the ﬁrst 8 weeks of
anti-tuberculosis treatment. With ongoing treatment duration, time to culture positivity decreased signiﬁcantly in supernatant-enriched
cultures, possibly due to stimulation of dormant or slowly metabolizing M. tuberculosis cells.
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